While clinical studies on IFN-γ-related systemic inflammation in subjects with asthma and obesity are limited, in vivo studies using obese mice lacking IFN-γ show a decrease in systemic inflammation, suggesting that IFN-γ plays a role in the regulation of systemic inflammation (131). Here, IFNG is linked to obesity due to melanocortin 4 receptor deficiency.